Thane Wettig Fibrogen Inc (FGEN) insider trading activity

Thane Wettig is CEO of FIBROGEN INC. Currently has a direct ownership of 422,316 shares of FGEN, which is worth approximately $126,694. The most recent transaction as insider was on Sep 06, 2024, when has been sold 2,363 shares (Common Stock) at a price of $0.39 per share, resulting in proceeds of $921. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 422K

0.56% 3M change

48.74% 12M change

Total Value Held $126,694

Thane Wettig Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 06 2024	SELL Payment of exercise price or tax liability	$921 $0.39 p/Share	2,363 Reduced 0.56%	422,316 Common Stock
Aug 01 2024	SELL Payment of exercise price or tax liability	$9,794 $0.47 p/Share	20,840 Reduced 4.68%	424,679 Common Stock
Jun 22 2024	SELL Payment of exercise price or tax liability	$883 $1.13 p/Share	782 Reduced 0.18%	445,519 Common Stock
Jun 06 2024	SELL Payment of exercise price or tax liability	$2,683 $1.19 p/Share	2,255 Reduced 0.5%	446,301 Common Stock
May 01 2024	SELL Payment of exercise price or tax liability	$24,382 $1.17 p/Share	20,840 Reduced 4.44%	448,556 Common Stock
Mar 22 2024	SELL Payment of exercise price or tax liability	$2,017 $2.58 p/Share	782 Reduced 0.17%	469,396 Common Stock
Mar 07 2024	BUY Open market or private purchase	$95,500 $1.91 p/Share	50,000 Added 9.61%	470,178 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$8,480 $1.87 p/Share	4,535 Reduced 1.07%	420,178 Common Stock
Mar 06 2024	BUY Grant, award, or other acquisition	-	781 Added 0.19%	420,504 Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	166,000 Added 28.14%	423,932 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$55,671 $2.37 p/Share	23,490 Reduced 8.35%	257,932 Common Stock
Dec 22 2023	SELL Payment of exercise price or tax liability	$622 $0.76 p/Share	819 Reduced 0.29%	281,422 Common Stock
Dec 06 2023	SELL Payment of exercise price or tax liability	$974 $0.58 p/Share	1,680 Reduced 0.59%	282,241 Common Stock
Nov 01 2023	SELL Payment of exercise price or tax liability	$12,012 $0.55 p/Share	21,841 Reduced 7.14%	283,921 Common Stock
Sep 22 2023	SELL Payment of exercise price or tax liability	$647 $0.79 p/Share	819 Reduced 0.27%	305,762 Common Stock
Sep 06 2023	SELL Payment of exercise price or tax liability	$1,612 $0.96 p/Share	1,680 Reduced 0.54%	306,581 Common Stock
Aug 07 2023	BUY Grant, award, or other acquisition	-	200,000 Added 39.35%	308,261 Common Stock
Jun 23 2023	SELL Open market or private sale	$13,075 $16.53 p/Share	791 Reduced 0.73%	108,261 Common Stock
Jun 07 2023	SELL Open market or private sale	$29,956 $17.04 p/Share	1,758 Reduced 1.55%	111,395 Common Stock
Mar 23 2023	SELL Open market or private sale	$16,932 $18.71 p/Share	905 Reduced 0.81%	110,653 Common Stock
Mar 20 2023	SELL Bona fide gift	-	2,343 Reduced 2.12%	108,310 Common Stock
Mar 10 2023	SELL Open market or private sale	$154,913 $20.2 p/Share	7,669 Reduced 6.43%	111,558 Common Stock
Mar 08 2023	SELL Open market or private sale	$132,567 $21.16 p/Share	6,265 Reduced 5.68%	104,090 Common Stock
Mar 08 2023	BUY Grant, award, or other acquisition	-	15,137 Added 11.27%	119,227 Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	-	25,000 Added 18.47%	110,355 Common Stock

Thane Wettig

CEO

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Fibrogen Inc insider buys or sells FGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to FIBROGEN INC

Track Activities on FGEN

Account